Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baptist Health South Florida
* Primary endpoint: To examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.
* Secondary endpoint: To assess the impact of such intervention on lipid profiles and hemoglobin A1C. The study group will be compared with a historical control group of patients with early stage breast cancer who are obese or overweight who were not given the intervention
* Secondary endpoint: To examine whether an active intervention program will lead into longstanding lifestyle modification in breast cancer patients with a BMI greater or equal to 25.
Age
18–89
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
DCIS
Women with stage 0 - III breast cancer (histologic type ductal or lobular)
BMI \>=25
Patients must have completed all chemotherapy
Patients may be on hormonal therapy or radiation therapy
Age \>= 18 years old to 89 Years old
Patient must be medically stable and without significant impairments that would preclude following the proposed intervention regimen.
Time of diagnosis: patients enrolled are within 1 month to 18 months post-diagnosis.
You may not be if
Metastatic breast cancer patients and patients with inoperable or active loco-regional disease.
Patients following alternative/complementary diets or taking high dose antioxidant supplements.
Patients with a physical/psychiatric impairment that would seriously impair their physical mobility.
Patients who are currently suffering from severe nausea, anorexia or other diseases affecting health (e.g. arthritis and multiple sclerosis).
